The current flu season is shaping up to be the worst in a decade. So far, there have been at least 29 million illnesses and 370,000 hospitalizations related to the flu—the most since the 2015–2016 season, according to the ...
Feb 21, 2025
0
17
Very early exposure to even a very small dose of herpes simplex virus (HSV) in infant mice can lead to cognitive decline later in life, according to findings from a new Dartmouth-led study, in collaboration with Harvard Medical ...
Feb 19, 2025
0
87
A virus originally found in animals, mpox—which causes the disease of the same name—is now circulating in humans. Since 2022, it has been the cause of major epidemics spreading outside endemic areas in Central and West Africa. ...
Feb 12, 2025
0
21
There's currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the disease, these are both costly and may have limited benefit for many patients.
Feb 5, 2025
0
20
Antibiotics, antivirals, vaccinations and anti-inflammatory medication are associated with reduced risk of dementia, according to new research that looked at health data from over 130 million individuals.
Jan 21, 2025
0
40
The World Health Organization (WHO) recently released new estimates suggesting around 846 million people aged between 15 and 49 live with a genital herpes infection.
Jan 20, 2025
0
46
The widening U.S. bird flu outbreak has made its way to Maryland, which has counted two cases on commercial poultry farms—one in Caroline County and another in Queen Anne's County—since the start of the year.
Jan 20, 2025
0
38
One of the earliest strains of bird flu isolated from a human in Texas shows a unique constellation of mutations that enable it to more easily replicate in human cells and cause more severe disease in mice compared to a strain ...
Jan 15, 2025
0
54
A research team has successfully utilized human respiratory organoids (mini-organs) to propagate human rhinovirus C (HRV-C), which had previously been refractory to conventional virus cultivation. This breakthrough opens ...
Jan 14, 2025
0
26
Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist, according to a case series published online Jan. 6 in Communications Medicine.
Jan 9, 2025
0
19
